New regulatory mechanism‐based inhibitors of aspartate transcarbamoylase for potential anticancer drug development-Reference-Cited by-同舟云学术

New regulatory mechanism‐based inhibitors of aspartate transcarbamoylase for potential anticancer drug development

Author:

Lei Zhen¹,Wang Biying¹,Lu Zhifang¹^ORCID,Wang Nan¹²,Tan Hongwei¹,Zheng Jimin¹^ORCID,Jia Zongchao³^ORCID

Affiliation:

1. College of Chemistry Beijing Normal University China

2. Jiangsu Key Laboratory of Brain Disease Bioinformation Research Center for Biochemistry and Molecular Biology Xuzhou Medical University China

3. Department of Biomedical and Molecular Sciences Queen's University Kingston Canada

Funder

Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

Reference45 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Patent Highlights June–July 2023;Pharmaceutical Patent Analyst;2024-04-26

3. PDB‐REDO in Computational‐Aided Drug Design ( CADD );Methods and Principles in Medicinal Chemistry;2023-10-20